Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ISRCTN52914430) titled 'Can providing Social Norms Feedback (SNF) intervention strategies to primar... Read More
Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ISRCTN14269651) titled 'Does an absorbable poloxamer and sodium alginate gel applied during lower-b... Read More
Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ISRCTN86586050) titled 'Effects of an infant formula containing hydrolysed protein on growth, toler... Read More
Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ISRCTN79465785) titled 'Outcomes of two surgical approaches for tibial eminence fractures' on July ... Read More
Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127804) titled 'A Single-Center, Open-Label, Randomized, Single-Dose, Four-Period, Two-Se... Read More
Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127809) titled 'Effects of Ultrasound Intervention on Clinical Outcomes and Tear Progress... Read More
Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127813) titled 'Early Immune Function Status in Severe Burns: Implications for Organ Inju... Read More
Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127819) titled 'Preliminary Efficacy Observation of Topical Beta-Carotene in Refractory E... Read More
Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127823) titled 'Prediction of Rapid Progression Risk in Type 2 Diabetic Nephropathy Based... Read More
Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127826) titled 'Iparomlimab and Tuvonralimab as first-line treatment for locally advanced... Read More